{"id":70492,"date":"2025-10-28T10:53:50","date_gmt":"2025-10-28T05:23:50","guid":{"rendered":"https:\/\/vajiramandravi.com\/current-affairs\/?p=70492"},"modified":"2025-10-28T10:53:50","modified_gmt":"2025-10-28T05:23:50","slug":"daily-editorial-analysis-28-october-2025","status":"publish","type":"post","link":"https:\/\/vajiramandravi.com\/current-affairs\/daily-editorial-analysis-28-october-2025\/","title":{"rendered":"Daily Editorial Analysis 28 October 2025"},"content":{"rendered":"<h2><strong>Big Tech\u2019s Contempt for Indian Public Health<\/strong><\/h2>\n<h3><strong>Context<\/strong><\/h3>\n<ul>\n<li><strong>Drug advertising<\/strong> has been a matter of public concern in India since <strong>1927<\/strong>, when <strong>Sir Haroon Jaffer<\/strong> raised the issue of <strong>control of the craze for medicinal drugs<\/strong> in the <strong>Council of State<\/strong>.<\/li>\n<li>The concern eventually led to the <strong>Drugs and Magic Remedies (Objectionable Advertisements) Act (DMRA), 1954<\/strong>, which <strong>prohibits advertisements<\/strong> for drugs claiming to cure or prevent a list of <strong>54 diseases and medical conditions<\/strong>.<\/li>\n<li>The purpose of this law was to <strong>protect citizens from misleading claims<\/strong> and <strong>pseudo-medical treatments<\/strong>.<\/li>\n<li>However, the <strong>digital age<\/strong> <strong>has transformed the advertising landscape<\/strong>. The rise of <strong>social media<\/strong>, <strong>search engines<\/strong>, and <strong>online marketplaces<\/strong> has created an environment where the <strong>spirit of the DMRA<\/strong> is routinely violated.<\/li>\n<\/ul>\n<h3><strong>The Evolution of Drug Advertising: From Legislative Vigilance to Digital Evasion<\/strong><\/h3>\n<ul>\n<li>The <strong>DMRA<\/strong> was crafted at a time when <strong>government oversight<\/strong> could effectively target <strong>print and broadcast media<\/strong>.<\/li>\n<li>In the <strong>digital era<\/strong>, this model no longer holds. <strong>Online advertising<\/strong> operates across borders, managed by <strong>algorithms<\/strong> and <strong>corporations based outside India<\/strong>.<\/li>\n<li>As a result, <strong>unverified medical advertisements<\/strong>, especially those promoting <strong>ayurvedic<\/strong>, <strong>homeopathic<\/strong>, or <strong>miracle\u201d cures<\/strong>, have multiplied on the Internet.<\/li>\n<li>Searches for products such as <strong>ayurveda blood pressure tablets<\/strong> or <strong>homeopathy diabetes cures<\/strong> routinely display <strong>paid promotions<\/strong> under <strong>sponsored tags<\/strong>.<\/li>\n<li>Many of these advertisements claim to treat <strong>serious conditions<\/strong> like <strong>diabetes<\/strong> and <strong>cancer<\/strong>, violating the <strong>DMRA\u2019s explicit prohibitions<\/strong>.<\/li>\n<li>The situation is made worse by <strong>promotional videos<\/strong> featuring <strong>spiritual figures<\/strong> who claim to cure all diseases using traditional medicine.<\/li>\n<li>Such practices have turned <strong>online platforms<\/strong> into powerful vehicles for <strong>misinformation<\/strong> that can endanger <strong>public health<\/strong>.<\/li>\n<\/ul>\n<h3><strong>Double Standards in Global Corporate Behaviour and Legal Evasion <\/strong><\/h3>\n<ul>\n<li>\n<h4><strong>Double Standards in Global Corporate Behaviour<\/strong><\/h4>\n<ul>\n<li>A striking contrast exists between the conduct of <strong>technology companies in India<\/strong> and their behaviour in the <strong>United States<\/strong>. In the U.S., <strong>health-related advertisements<\/strong> are tightly controlled.<\/li>\n<li>Platforms employ <strong>pre-screening systems<\/strong> and adhere to detailed <strong>content guidelines<\/strong> to ensure compliance with laws enforced by agencies such as the <strong>Food and Drug Administration (FDA)<\/strong>.<\/li>\n<li><strong>False or unapproved therapeutic claims<\/strong> are swiftly removed, and violations invite <strong>criminal prosecution<\/strong>.<\/li>\n<li>In India, the same companies apply <strong>no such rigour<\/strong>. Their <strong>advertising policies<\/strong> make no mention of the <strong>DMRA<\/strong> or its prohibitions, enabling advertisers to promote <strong>unverified medical products<\/strong>.<\/li>\n<li>This <strong>double standard<\/strong> exposes a clear <strong>hierarchy in corporate compliance<\/strong>. Companies obey strong regulations in Western nations but neglect similar responsibilities in developing ones.<\/li>\n<\/ul>\n<\/li>\n<li>\n<h4><strong>Legal Evasion and Institutional Weakness<\/strong><\/h4>\n<ul>\n<li>Technology companies often justify their inaction by claiming <strong>intermediary status<\/strong> under Indian law, a designation that shields them from <strong>liability<\/strong> for <strong>user-generated content<\/strong>.<\/li>\n<li>Yet this argument collapses in the context of <strong>paid advertising<\/strong>.<\/li>\n<li>Advertisements are not user-generated; they are <strong>actively solicited, approved, and monetised<\/strong> by the platforms themselves. <strong>Contracts<\/strong> are signed, <strong>payments<\/strong> are accepted, and <strong>advertising slots<\/strong> are deliberately allocated.<\/li>\n<li>These are the actions of <strong>publishers<\/strong>, not passive intermediaries.<\/li>\n<li><strong>Regulatory weakness<\/strong> compounds the problem. The <strong>Public Interest Litigation (PIL)<\/strong> filed in <strong>2008<\/strong> over violations of the <strong>Pre-Conception and Pre-Natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994 (PNDT)<\/strong> offers a telling example.<\/li>\n<li>Accountability is further weakened by the <strong>legal separation<\/strong> between <strong>Indian subsidiaries<\/strong> and their <strong>S.-based parent companies<\/strong>.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>The Way Forward: Reclaiming Sovereignty through Reform<\/strong><\/h3>\n<ul>\n<li>Addressing these failures requires firm <strong>regulatory and legal reform<\/strong>.<\/li>\n<li><strong>Criminal proceedings<\/strong> against responsible managerial personnel would mark a decisive step toward enforcement.<\/li>\n<li>Mandating that key decision-makers for <strong>advertising and content operations<\/strong> in India be <strong>citizens based in India<\/strong> would ensure accountability to domestic courts and laws.<\/li>\n<li>Such measures would align India\u2019s <strong>digital governance<\/strong> with its <strong>sovereign right<\/strong> to protect public health.<\/li>\n<li>Another necessary reform is the <strong>conditional revocation of intermediary immunity<\/strong>.<\/li>\n<li>Platforms that disregard laws like the <strong>DMRA<\/strong> should not benefit from the protections granted to neutral intermediaries.<\/li>\n<li><strong>Immunity must be<\/strong> <strong>contingent on compliance<\/strong> with Indian law. Without this condition, the privilege becomes an <strong>instrument of impunity<\/strong> rather than <strong>innovation<\/strong>.<\/li>\n<\/ul>\n<h3><strong>Conclusion<\/strong><\/h3>\n<ul>\n<li>The history of India\u2019s struggle against <strong>misleading medical advertisements<\/strong>, beginning in <strong>1927<\/strong> and codified in <strong>1954<\/strong>, reveals a continuous tension between <strong>public welfare<\/strong> and <strong>commercial exploitation<\/strong>.<\/li>\n<li>The digital era has intensified this conflict, as <strong>foreign corporations<\/strong> exploit <strong>legal loopholes<\/strong> and <strong>weak enforcement<\/strong> to profit from <strong>misinformation<\/strong>.<\/li>\n<li>The unchecked spread of <strong>unverified health claims<\/strong> not only undermines the <strong>DMRA<\/strong> but also <strong>endangers millions<\/strong> who rely on such remedies in good faith.<\/li>\n<li>Restoring accountability demands a <strong>reassertion of legal authority<\/strong>, the creation of <strong>transparent enforcement mechanisms<\/strong>, and the <strong>political will<\/strong> to treat violations as <strong>serious crimes<\/strong> rather than administrative oversights.<\/li>\n<\/ul>\n<h3><strong>Big Tech\u2019s Contempt for Indian Public Health\u00a0FAQs<\/strong><\/h3>\n<p><strong>Q1. <\/strong>What is the main purpose of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954?<br \/>\n<strong>Ans. <\/strong>The main purpose of the DMRA is to prohibit advertisements that make false or misleading claims about curing or preventing certain diseases and to protect the public from deceptive medical promotions.<\/p>\n<p><strong>Q2. <\/strong>How has the rise of the Internet affected drug advertising in India?<br \/>\n<strong>Ans. <\/strong>The rise of the Internet has made it easier for companies to spread unverified medical claims through digital platforms that operate beyond India\u2019s legal control.<\/p>\n<p><strong>Q3. <\/strong>Why do Big Tech companies face criticism in the context of Indian drug advertisement laws?<br \/>\n<strong>Ans. <\/strong>Big Tech companies face criticism because they enforce strict health advertising rules in countries like the United States but ignore similar laws such as the DMRA in India.<\/p>\n<p><strong>Q4. <\/strong>What legal loophole allows technology companies to avoid punishment for violating Indian laws?<br \/>\n<strong>Ans. <\/strong>Technology companies use the \u201cintermediary\u201d status under Indian law to claim immunity from liability, even though they actively manage and profit from paid advertisements.<\/p>\n<p><strong>Q5. <\/strong>What reforms are suggested to make Big Tech accountable in India?<br \/>\n<strong>Ans. <\/strong>Suggested reforms include prosecuting responsible executives, requiring India-based managers for advertising decisions, and revoking intermediary immunity for non-compliant platforms.<\/p>\n<p><strong>Source: <\/strong><a href=\"https:\/\/www.thehindu.com\/opinion\/lead\/big-techs-contempt-for-indian-public-health\/article70209341.ece\" target=\"_blank\" rel=\"nofollow noopener\"><strong>The Hindu<\/strong><\/a><\/p>\n<hr \/>\n<h2><strong>A Start for North-South Carbon Market Cooperation<\/strong><\/h2>\n<h3><strong>Context<\/strong><\/h3>\n<ul>\n<li>The <strong>European Union (EU)<\/strong> and <strong>India\u2019s New Strategic EU\u2013India Agenda<\/strong>, announced on <strong>September 17, 2025<\/strong>, marks a <strong>significant milestone<\/strong> in their evolving partnership.<\/li>\n<li>Structured around <strong>five key pillars<\/strong>; <strong>prosperity and sustainability<\/strong>, <strong>technology and innovation<\/strong>, <strong>security and defence<\/strong>, <strong>connectivity and global issues<\/strong>, and <strong>cross-cutting enablers<\/strong>, the agenda seeks to deepen collaboration across economic and geopolitical domains.<\/li>\n<li>Among its most consequential features lies a <strong>seemingly technical but transformative proposal<\/strong>: linking <strong>India\u2019s Carbon Market (ICM)<\/strong> with the <strong>EU\u2019s Carbon Border Adjustment Mechanism (CBAM)<\/strong>.<\/li>\n<\/ul>\n<h3><strong>The Promise of the Linkage and the Structural Weakness of India\u2019s Carbon Market<\/strong><\/h3>\n<ul>\n<li>\n<h4><strong>The Promise of the Linkage<\/strong><\/h4>\n<ul>\n<li>At its core, the proposed <strong>linkage between the Indian Carbon Market and CBAM<\/strong> offers a <strong>pragmatic solution<\/strong> to a pressing challenge: the <strong>risk of double carbon penalties<\/strong> for Indian exporters.<\/li>\n<li>Under <strong>CBAM<\/strong>, the EU imposes a <strong>carbon levy on imports<\/strong> based on the <strong>embedded emissions in goods<\/strong>, ensuring a <strong>level playing field<\/strong> with domestic producers who already pay carbon prices under the <strong>EU Emissions Trading System (ETS)<\/strong>.<\/li>\n<li>By allowing <strong>carbon costs paid within India<\/strong> to be <strong>deducted<\/strong> from <strong>CBAM charges<\/strong> at the EU border, exporters would be spared the <strong>unfair burden of dual payments<\/strong>.<\/li>\n<li>This arrangement could <strong>incentivise early decarbonisation<\/strong>, <strong>align domestic emissions reductions<\/strong> with <strong>global trade competitiveness<\/strong>, and reflect a rare case of <strong>climate justice in practice<\/strong>, <strong>recognising<\/strong> rather than <strong>penalising<\/strong> developing country efforts in carbon pricing.<\/li>\n<\/ul>\n<\/li>\n<li>\n<h4><strong>The Structural Weakness of India\u2019s Carbon Market<\/strong><\/h4>\n<ul>\n<li>Yet this vision rests on a <strong>shaky institutional foundation<\/strong>. India\u2019s <strong>Carbon Credit Trading Scheme (CCTS)<\/strong>, commonly called the <strong>Indian Carbon Market (ICM)<\/strong>, remains <strong>underdeveloped<\/strong> compared to the <strong>EU\u2019s mature ETS<\/strong>.<\/li>\n<li>While the <strong>EU ETS<\/strong> has a <strong>two-decade track record<\/strong> of <strong>auction mechanisms<\/strong>, <strong>strict emission caps<\/strong>, and <strong>independent verification<\/strong>, India\u2019s system is <strong>fragmented<\/strong> and <strong>experimental<\/strong>.<\/li>\n<li>Its current credits often rely on <strong>project-based offsets<\/strong> or <strong>efficiency improvements<\/strong> rather than <strong>binding absolute emission caps<\/strong>.<\/li>\n<li>For <strong>CBAM\u2019s tonne-for-tonne accounting<\/strong> to work credibly, the <strong>EU must trust<\/strong> that India\u2019s carbon credits <strong>represent verifiable emission reductions<\/strong>.<\/li>\n<li>However, the <strong>absence of strong regulators<\/strong>, <strong>transparent registries<\/strong>, and <strong>compliance enforcement<\/strong> undermines that trust.<\/li>\n<li>Unless India <strong>upgrades its carbon market<\/strong> to a <strong>compliance-grade mechanism<\/strong> with <strong>legal enforceability<\/strong>, the EU is <strong>unlikely to accept Indian carbon prices<\/strong> as valid deductions.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>The Carbon Price Gap and Political Economy Risks<\/strong><\/h3>\n<ul>\n<li>Even if institutional reforms succeed, a major <strong>price disparity<\/strong> The <strong>EU ETS carbon price<\/strong> fluctuates between <strong>\u20ac60 and \u20ac80 per tonne<\/strong>, while India\u2019s nascent market trades at <strong>\u20ac5 to \u20ac10 per tonne<\/strong>.<\/li>\n<li>Without <strong>price parity<\/strong> or <strong>alignment<\/strong>, EU regulators will <strong>deduct only minimal amounts<\/strong>, undermining the intended relief for exporters.<\/li>\n<li>This creates serious <strong>political and industrial risks<\/strong> in India. Exporters could face <strong>double burdens<\/strong>, paying both the <strong>domestic compliance cost<\/strong> and the <strong>full CBAM levy<\/strong>, leading to <strong>industrial resistance<\/strong> and <strong>pressure to dilute carbon rules<\/strong>.<\/li>\n<li>The resulting <strong>political economy tension<\/strong>, between <strong>industrial competitiveness<\/strong> and <strong>environmental ambition<\/strong>, is a central obstacle.<\/li>\n<li>Possible solutions such as <strong>sectoral carbon contracts<\/strong> or a <strong>negotiated carbon price floor<\/strong> are <strong>technically feasible<\/strong> but <strong>politically delicate<\/strong>, requiring <strong>long-term coordination<\/strong> between <strong>New Delhi and Brussels<\/strong>.<\/li>\n<\/ul>\n<h3><strong>The Geopolitical Contradictions of CBAM and the Way Forward<\/strong><\/h3>\n<ul>\n<li>\n<h4><strong>The Geopolitical Contradictions of CBAM<\/strong><\/h4>\n<ul>\n<li>Beyond economics, the <strong>CBAM\u2013ICM linkage<\/strong> raises <strong>geopolitical and sovereignty concerns<\/strong>.<\/li>\n<li>India, along with other developing nations, has <strong>opposed CBAM<\/strong> at the <strong>World Trade Organization (WTO)<\/strong> and in <strong>international climate dialogues<\/strong>, labelling it <strong>unilateral<\/strong> and <strong>protectionist<\/strong>.<\/li>\n<li>By agreeing to integrate its carbon market with CBAM, India risks <strong>legitimising<\/strong> a mechanism it has <strong>formally resisted<\/strong>.<\/li>\n<li>This contradiction could trigger <strong>future disputes<\/strong>: if the EU deems India\u2019s <strong>carbon prices insufficient<\/strong>, exporters may face <strong>partial or full CBAM penalties<\/strong>, prompting <strong>political escalation<\/strong> or <strong>legal challenge<\/strong>.<\/li>\n<\/ul>\n<\/li>\n<li>\n<h4><strong>The Way Forward: Toward a Cooperative Future<\/strong><\/h4>\n<ul>\n<li>Despite its challenges, the <strong>CBAM\u2013ICM linkage<\/strong> holds <strong>transformative potential<\/strong>.<\/li>\n<li>If implemented successfully, it could become a <strong>global model<\/strong> for <strong>North\u2013South carbon market cooperation<\/strong>.<\/li>\n<li>It would <strong>protect Indian exporters<\/strong>, <strong>accelerate industrial decarbonisation<\/strong>, and <strong>strengthen EU\u2013India climate diplomacy<\/strong>.<\/li>\n<li>Achieving this outcome requires a <strong>phased and transparent approach<\/strong>, where <strong>India strengthens its market integrity<\/strong> and <strong>the EU provides technical and policy support<\/strong>.<\/li>\n<li>Only through <strong>collaborative design<\/strong>, <strong>clear equivalence criteria<\/strong>, and <strong>joint monitoring mechanisms<\/strong> can the two sides translate ambition into action.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3><strong>Conclusion<\/strong><\/h3>\n<ul>\n<li>The proposed <strong>linkage between India\u2019s carbon market and the EU\u2019s CBAM<\/strong> represents both a <strong>visionary step<\/strong> toward <strong>global carbon fairness<\/strong> and a <strong>minefield of practical and political challenges<\/strong>.<\/li>\n<li>Its success depends on <strong>reconciling divergent regulatory standards<\/strong>, <strong>closing price gaps<\/strong>, and <strong>navigating geopolitical sensitivities<\/strong>.<\/li>\n<li>Without careful coordination, this <strong>breakthrough<\/strong> risks remaining a <strong>symbolic gesture<\/strong>, a <strong>promising clause buried in diplomacy<\/strong>.<\/li>\n<li>But if <strong>India and the EU<\/strong> commit to <strong>mutual trust<\/strong>, <strong>transparency<\/strong>, and <strong>shared responsibility<\/strong>, this initiative could <strong>redefine global climate cooperation<\/strong> and <strong>set a precedent<\/strong> for equitable transitions in the <strong>21st century<\/strong>.<\/li>\n<\/ul>\n<h3><strong>A Start for North-South Carbon Market Cooperation FAQs<\/strong><\/h3>\n<p><strong>Q1. <\/strong>What is the main purpose of linking the Indian Carbon Market (ICM) with the EU\u2019s Carbon Border Adjustment Mechanism (CBAM)?<br \/>\n<strong>Ans. <\/strong>The main purpose is to prevent Indian exporters from paying double carbon costs and to encourage early industrial decarbonisation.<\/p>\n<p><strong>Q2.<\/strong> Why is India\u2019s carbon market considered underdeveloped compared to the EU\u2019s Emissions Trading System (ETS)?<br \/>\n<strong>Ans. <\/strong>India\u2019s carbon market lacks binding emission caps, independent verification, and strong regulatory institutions, unlike the EU\u2019s well-established ETS.<\/p>\n<p><strong>Q3.<\/strong> What major challenge arises from the carbon price gap between India and the EU?<br \/>\n<strong>Ans. <\/strong>The large price gap means EU regulators may deduct very little at the border, causing Indian exporters to face both domestic carbon costs and full CBAM levies.<\/p>\n<p><strong>Q4.<\/strong> Why is CBAM politically controversial for India?<br \/>\n<strong>Ans. <\/strong>CBAM is controversial because India has opposed it as a protectionist and unilateral measure, and linking with it could appear to legitimise a mechanism it previously resisted.<\/p>\n<p><strong>Q5.<\/strong> What could make the EU\u2013India carbon market linkage successful in the future?<br \/>\n<strong>Ans. <\/strong>The linkage could succeed if India strengthens its carbon market integrity and the EU provides technical support and flexibility in recognizing India\u2019s carbon pricing efforts.<\/p>\n<p><strong>Source: <\/strong><a href=\"https:\/\/www.thehindu.com\/opinion\/op-ed\/a-start-for-north-south-carbon-market-cooperation\/article70209291.ece#:~:text=The%20Indian%20carbon%20market%20and,North%2DSouth%20carbon%20market%20cooperation.\" target=\"_blank\" rel=\"nofollow noopener\"><strong>The Hindu<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Daily Editorial Analysis 28 October 2025 by Vajiram &#038; Ravi covers key editorials from The Hindu &#038; Indian Express with UPSC-focused insights and relevance.<\/p>\n","protected":false},"author":20,"featured_media":50653,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[138],"tags":[141,882,909],"class_list":{"0":"post-70492","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-daily-editorial-analysis","8":"tag-daily-editorial-analysis","9":"tag-the-hindu-editorial-analysis","10":"tag-the-indian-express-analysis","11":"no-featured-image-padding"},"acf":[],"_links":{"self":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/70492","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/comments?post=70492"}],"version-history":[{"count":0,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/70492\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media\/50653"}],"wp:attachment":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media?parent=70492"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/categories?post=70492"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/tags?post=70492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}